Mads Hald Andersen
Clinical Professor
Immunology
Blegdamsvej 3B, 2200 København N
Member of:
- 2023
- Published
of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes
Hulen, T. M., Friese, C., Kristensen, N. P., Granhøj, J. S., Borch, T. H., Peeters, M. J. W., Donia, M., Andersen, Mads Hald, Hadrup, S. R., Svane, Inge Marie & Met, Özcan, 2023, In: Frontiers in Immunology. 14, 15 p., 1180997.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial
Grauslund, J. H., Holmström, M. O., Martinenaite, E., Lisle, T. L., Glöckner, H. J., Fassi, Daniel El , Klausen, U., Mortensen, R. E. J., Jørgensen, N., Kjær, L., Skov, V., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2023, In: Frontiers in Immunology. 14, 14 p., 1117466.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Antibodies to calnexin and mutated calreticulin are common in human sera
Kyllesbech, C., Trier, N. H., Mughal, F. P., Hansen, Paul Robert, Holmström, M. O., Fassi, Daniel El , Hasselbalch, H., Skov, V., Kjær, L., Andersen, Mads Hald, Ciplys, E., Slibinskas, R., Fredriksen, Jette Lautrup, Højrup, P. & Houen, G., 2023, In: Current Research in Translational Medicine. 71, 2, 103380.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer
Mørk, S. K., Kongsted, P., Westergaard, M. C. W., Albieri, B., Granhøj, J. S., Donia, M., Martinenaite, E., Holmström, M. O., Madsen, K., Kverneland, A. H., Kjeldsen, J. W., Holmstroem, R. B., Lorentzen, C. L., Nørgaard, N., Andreasen, L. V., Wood, G. K., Christensen, D., Klausen, M. S., Hadrup, S. R., thor Straten, P. & 2 others, , 2023, In: Frontiers in Immunology. 14, 1122977.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immune modulatory vaccines: time to move into infectious diseases
Andersen, Mads Hald, 2023, In: The Lancet Microbe. 4, 1, p. e4-e5Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Novel immune modulatory vaccines targeting TGFβ
Andersen, Mads Hald, 2023, In: Cellular and Molecular Immunology. 20, p. 551–553Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment
Andersen, Mads Hald, 2023, In: Seminars in Immunopathology. 45, 2, p. 159-161 3 p.Research output: Contribution to journal › Editorial › Research › peer-review
- Published
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy
Mortensen, R. E. J., Holmström, M. O., Lisle, T. L., Hasselby, Jane Preuss, Willemoe, G. L., Met, Özcan, Svane, Inge Marie, Johansen, Julia Sidenius, Nielsen, Dorte Lisbet, Chen, I. M. & Andersen, Mads Hald, 2023, In: Journal for ImmunoTherapy of Cancer. 11, 3Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms
Hasselbalch, Hans Carl, Junker, P., Skov, V., Kjær, L., Knudsen, T. A., Larsen, Morten Kranker, Holmström, M. O., Andersen, Mads Hald, Jensen, C., Karsdal, M. A. & Willumsen, N., 2023, In: Cancers. 15, 17, 47 p., 4323.Research output: Contribution to journal › Review › Research › peer-review
- Published
Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow
Holmström, M. O., Andersen, M., Traynor, S., Ahmad, S. M., Lisle, T. L., Handlos Grauslund, J., Skov, V., Kjær, L., Ottesen, J. T., Gjerstorff, M. F., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2023, In: Frontiers in Immunology. 14, 14 p., 1240678.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Tumor microenvironment antigens
Andersen, Mads Hald, 2023, In: Seminars in Immunopathology. 45, p. 253–264Research output: Contribution to journal › Review › Research › peer-review
- 2022
- Published
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV
Klausen, U., Grauslund, J. H., Jørgensen, N. G. D., Ahmad, S. M., Jonassen, M., Weis-Banke, S. E., Martinenaite, E., Pedersen, L. B., Lisle, T. L., Gang, Anne Ortved, Enggaard, L., Hansen, M., Holmström, M. O., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2022, In: Frontiers in Oncology. 12, 1023015.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial
Lorentzen, C. L., Martinenaite, E., Kjeldsen, J. W., Holmstroem, R. B., Mørk, S. K., Pedersen, A. W., Ehrnrooth, E., Andersen, Mads Hald & Svane, Inge Marie, 2022, In: Frontiers in Immunology. 13, 1023023.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells
Weis-Banke, S. E., Lisle, T. L., Perez Penco, Maria, Schina, A., Hübbe, M. L., Siersbæk, M., Holmström, M. O., Jørgensen, M. A., Svane, Inge Marie, Met, Özcan, Ødum, Niels, Madsen, Daniel Hargbøl, dqp123, dqp123, Grøntved, L. & Andersen, Mads Hald, 2022, In: Journal for ImmunoTherapy of Cancer. 10, 10, e005326.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment
Lecoq, I., Kopp, K. L., Chapellier, M., Mantas, P., Martinenaite, E., Perez Penco, Maria, Rønn Olsen, L., Zocca, M. B., Wakatsuki Pedersen, A. & Andersen, Mads Hald, 2022, In: OncoImmunology. 11, 1, 2115655.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
Gigoux, M., Holmström, M. O., Zappasodi, R., Park, J. J., Pourpe, S., Bozkus, C. C., Mangarin, L. M. B., Redmond, D., Verma, S., Schad, S., George, M. M., Venkatesh, D., Ghosh, A., Hoyos, D., Molvi, Z., Kamaz, B., Marneth, A. E., Duke, W., Leventhal, M. J., Jan, M. & 23 others, , 2022, In: Science Translational Medicine. 14, 649, eaba4380.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immune modulatory vaccines: the safe way to inflame the tumor microenvironment & guide anti-cancer immunotherapies
Andersen, Mads Hald, 2022, In: Immuno Oncology Insights. 3, 9, p. 401-407Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression
Carnaz Simões, A. M., Holmström, M. O., Aehnlich, P., Rahbech, Anne, Radziwon-Balicka, A., Zamora, C., Wirenfeldt Klausen, T., Skov, V., Kjær, L., Ellervik, Christina, Fassi, Daniel El , Vidal, S., Hasselbalch, Hans Carl, Andersen, Mads Hald & thor Straten, P., 2022, In: Frontiers in Immunology. 13, 866610.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment
Bendtsen, S. K., Perez Penco, Maria, Hübbe, M. L., Martinenaite, E., Orebo Holmström, M., Weis-Banke, S. E., Grønne Dahlager Jørgensen, N., Jørgensen, M. A., Munir Ahmad, S., Jensen, K. M., Friese, C., Lundsager, M. T., Johansen, A. Z., Carretta, M., Ødum, Niels, Met, Özcan, Svane, Inge Marie, Madsen, Daniel Hargbøl & Andersen, Mads Hald, 2022, In: OncoImmunology. 11, 1, 2026020.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer
Perez Penco, Maria, Weis-Banke, S. E., Schina, A., Siersbæk, M., Hübbe, M. L., Jørgensen, M. A., Lecoq, I., Lara De La Torre, L., Bendtsen, S. K., Martinenaite, E., Holmström, M. O., Madsen, Daniel Hargbøl, dqp123, dqp123, Ødum, Niels, Grøntved, L. & Andersen, Mads Hald, 2022, In: Journal for ImmunoTherapy of Cancer. 10, 12, 15 p., e005491.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Therapeutic Potential of an Immune-Modulatory Vaccination Targeting Myeloid-Derived Suppressor Cells in Myelodysplastic Syndrome
Bentivegna, Sofia, Holmstrøm, M., Balhuizen, Alexander, Almosailleakh, M., Perez Penco, Maria, Porse, Bo Torben, Andersen, Mads Hald & Grønbæk, Kirsten, 2022, In: Blood. 140, Suppl. 1, p. 4007-4008 2 p.Research output: Contribution to journal › Conference abstract in journal › Research
- 2021
- Published
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms
Handlos Grauslund, J., Holmström, M. O., Jørgensen, N. G., Klausen, U., Weis-Banke, S. E., El Fassi, D., Schöllkopf, C., Clausen, M. B., Gjerdrum, L. M. R., Breinholt, M. F., Kjeldsen, J. W., Hansen, M., Koschmieder, S., Chatain, N., Novotny, G. W., Petersen, J., Kjær, L., Skov, V., Met, Ö., Svane, I. M. & 2 others, , 26 Feb 2021, In: Frontiers in Oncology. 11, 17 p., 637420.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cytotoxic T cells isolated from healthy donors and cancer patients kill TGFβ-expressing cancer cells in a TGFβ-dependent manner
Holmström, M. O., Mortensen, R. E. J., Pavlidis, A. M., Martinenaite, E., Weis-Banke, S. E., Aaboe-Jørgensen, M., Bendtsen, S. K., Met, Özcan, Pedersen, A. W., Donia, M., Svane, Inge Marie & Andersen, Mads Hald, Feb 2021, In: Cellular and Molecular Immunology. 18, 2, p. 415-426 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
Kjeldsen, J. W., Lorentzen, C. L., Martinenaite, E., Ellebaek, E., dqp123, dqp123, Holmstroem, R. B., Klausen, T. W., Madsen, C. O., Ahmed, S. M., Weis-Banke, S. E., Holmström, M. O., Hendel, Helle Westergren, Ehrnrooth, E., Zocca, M. B., Pedersen, A. W., Andersen, Mads Hald & Svane, Inge Marie, 2021, In: Nature Medicine. 27, p. pages2212–2223Research output: Contribution to journal › Journal article › Research › peer-review
- Published
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma
Klausen, U., Grønne Dahlager Jørgensen, N., Grauslund, J. H., Munir Ahmad, S., Gang, Anne Ortved, Martinenaite, E., Weis-Banke, S. E., Breinholt, M. F., Novotny, G. W., Kjeldsen, J. W., Orebo Holmström, M., Pedersen, L. B., Poulsen, C. B., Hansen, P. B., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2021, In: OncoImmunology. 10, 1, 1975889.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Arginase 1–Based immune modulatory vaccines induce anticancer immunity and synergize with Anti–PD-1 checkpoint blockade
Jørgensen, M. A., Ugel, S., Hübbe, M. L., Carretta, M., Perez Penco, Maria, Weis-Banke, S. E., Martinenaite, E., Kopp, K., Chapellier, M., Adamo, A., de Sanctis, F., Frusteri, C., Iezzi, M., Zocca, M. B., Madsen, Daniel Hargbøl, Pedersen, A. W., Bronte, V. & Andersen, Mads Hald, 2021, In: Cancer Immunology Research. 9, 11, p. 1316-1326 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells
Mortensen, R. E. J., Holmström, M. O. & Andersen, Mads Hald, 2021, In: Cellular and Molecular Immunology. 18, 11, p. 2575-2577 3 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Lynch syndrome-associated epithelial ovarian cancer and its immunological profile
Rasmussen, M., Lim, K., Rambech, E., Andersen, Mads Hald, Svane, Inge Marie, Andersen, Ove, Jensen, L. H., Nilbert, Mef Christina & Therkildsen, C., 2021, In: Gynecologic Oncology. 162, 3, p. 686-693Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNϒ, Following Recognition of Autologous Tumor-Antigens
Draghi, A., Chamberlain, C. A., Khan, S., Papp, K., Lauss, M., Soraggi, S., Radic, H. D., Presti, M., Harbst, K., Gokuldass, A., Kverneland, Anders Handrup, Nielsen, M., Westergaard, M. C. W., Andersen, Mads Hald, Csabai, I., Jönsson, G., Szallasi, Z., Svane, Inge Marie & dqp123, dqp123, 2021, In: Frontiers in Immunology. 12, 13 p., 705422.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Vaccination against pd-l1 with io103 a novel immune modulatory vaccine in basal cell carcinoma: A phase iia study
Jørgensen, N. G., Kaae, Jeanette, Grauslund, J. H., Met, Özcan, Nielsen, S. L., Pedersen, A. W., Svane, Inge Marie, Ehrnrooth, E., Andersen, Mads Hald, Zachariae, Claus & Skov, Lone, 2021, In: Cancers. 13, 4, p. 1-15 15 p., 911.Research output: Contribution to journal › Journal article › Research › peer-review
- 2020
- Published
Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma
Blümel, E., Munir Ahmad, S., Nastasi, C., Willerslev-Olsen, A., Gluud, M., Fredholm, S., Hu, T., Surewaard, B. G. J., Lindahl, L. M., Fogh, H., Koralov, S. B., Rahbek Gjerdrum, L. M., Clark, R. A., Iversen, L., Krejsgaard, T., Bonefeld, C. M., Geisler, C., Becker, J. C., Woetmann, A., Andersen, M. H. & 2 others, , 2020, In: OncoImmunology. 9, 1, 9 p., 1751561.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome
Willerslev-Olsen, A., Buus, Terkild Brink, Nastasi, C., Blümel, E., Gluud, Maria, Bonefeld, Charlotte Menne, Geisler, Carsten, Lindahl, L. M., Vermeer, M., Wasik, M. A., Iversen, L., Becker, J. C., Andersen, Mads Hald, Gjerdrum, Lise Mette Rahbek, Litvinov, I. V., Litman, Thomas, Krejsgaard, T., Woetmann, Anders & Ødum, Niels, 2020, In: Blood Cancer Journal. 10, 5, 11 p., 57.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cancer immune therapy for Philadelphia chromosome-negative chronic myeloproliferative neoplasms
Holmström, M. O., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2020, In: Cancers. 12, 7, p. 1-21 21 p., 1763.Research output: Contribution to journal › Review › Research › peer-review
- Published
Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer
Holmström, M. O., Cordua, S., Skov, V., Kjær, L., Pallisgaard, N., Ellervik, Christina, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2020, In: Cancer Immunology, Immunotherapy. 69, p. 315–324Research output: Contribution to journal › Review › Research › peer-review
- Published
Healthy donors harbor memory T cell responses to RAS neo-antigens
Holmström, M. O. & Andersen, Mads Hald, 2020, In: Cancers. 12, 10, p. 1-16 16 p., 3045.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade
Hübbe, M. L., Jæhger, D. E., Andresen, T. L. & Andersen, Mads Hald, 2020, In: Frontiers in Immunology. 11, 578349.Research output: Contribution to journal › Review › Research › peer-review
- Published
MicroRNAs in the pathogenesis, diagnosis, prognosis and targeted treatment of cutaneous T-cell lymphomas
Gluud, Maria, Willerslev-Olsen, A., Gjerdrum, Lise Mette Rahbek, Lindahl, L. M., Buus, Terkild Brink, Andersen, Mads Hald, Bonefeld, Charlotte Menne, Krejsgaard, T., Litvinov, I. V., Iversen, L., Becker, J. C., Persson, J. L., Koralov, S. B., Litman, Thomas, Geisler, Carsten, Woetmann, Anders & Ødum, Niels, 2020, In: Cancers. 12, 5, 18 p., 1229.Research output: Contribution to journal › Review › Research › peer-review
- Published
Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial
Jørgensen, N. G., Klausen, U., Grauslund, J. H., Helleberg, C., Aagaard, T. G., Do, T. H., Ahmad, S. M., Olsen, L. R., Klausen, T. W., Breinholt, M. F., Hansen, M., Martinenaite, E., Met, Özcan, Svane, Inge Marie, Knudsen, L. M. & Andersen, Mads Hald, 2020, In: Frontiers in Immunology. 11, 11 p., 595035.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Peptide vaccination directed against IDO1-expressing immune cells elicits CD8 + and CD4 + T-cell-mediated antitumor immunity and enhanced anti-PD1 responses
Dey, S., Sutanto-Ward, E., Kopp, K. L., Duhadaway, J., Mondal, A., Ghaban, D., Lecoq, I., Zocca, M. B., Merlo, L. M. F., Mandik-Nayak, L., Andersen, Mads Hald, Pedersen, A. W. & Muller, A. J., 2020, In: Journal for ImmunoTherapy of Cancer. 8, 2, 2020000605.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines
Weis-Banke, S. E., Hübbe, M. L., Holmström, M. O., Jørgensen, M. A., Bendtsen, S. K., Martinenaite, E., Carretta, M., Svane, Inge Marie, Ødum, Niels, Pedersen, A. W., Met, Özcan, Madsen, D. H. & Andersen, Mads Hald, 2020, In: OncoImmunology. 9, 1, 16 p., 1771142.Research output: Contribution to journal › Journal article › Research › peer-review
- 2019
- Published
Anti-cancer immunotherapy: breakthroughs and future strategies
Andersen, Mads Hald, 2019, In: Seminars in Immunopathology. 41, 1, p. 1-3 3 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope
Martinenaite, E., Ahmad, S. M., Bendtsen, S. K., Jørgensen, M. A., Weis-Banke, S. E., Svane, Inge Marie & Andersen, Mads Hald, 2019, In: Cancer Immunology, Immunotherapy. 68, 11, p. 1901-1907 7 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon-α2, or combination treatment
Sørensen, A. L., Bjørn, M. E., Riley, C. H., Holmstrøm, M., Andersen, Mads Hald, Svane, Inge Marie, Mikkelsen, S. U., Skov, V., Kjær, L., Hasselbalch, H. C. & Nielsen, C. H., 2019, In: European Journal of Haematology. 103, 4, p. 351-361 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cancer immune therapy for lymphoid malignancies: recent advances
Klausen, U., Jorgensen, N. G. D., Grauslund, J. H., Holmstrom, M. O. & Andersen, Mads Hald, 2019, In: Seminars in Immunopathology. 41, 1, p. 111-124Research output: Contribution to journal › Review › Research › peer-review
- Published
Cancerimmunterapi til behandling af hæmatologisk cancer
Holmström, M. O., Klausen, U., Jørgensen, N. G., Holmberg, S., Grauslund, J., Met, Ö., Svane, Inge Marie, Pedersen, Lars Møller, Knudsen, L. M., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2019, In: Ugeskrift for Laeger. 181, 10, 5 p., V06180421.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome
Hu, T., Buus, T. B., Krejsgaard, T., Nansen, A., Lundholt, B. K., Spee, P., Fredholm, S., Petersen, D. L., Blümel, E., Gluud, M., Monteiro, M. N., Willerslev-Olsen, A., Andersen, M. H., Straten, P. T., Met, Ö., Stolearenco, V., Fogh, H., Gniadecki, R., Nastasi, C., Litman, T. & 3 others, , 2019, In: OncoTarget. 10, 47, p. 4894-4906 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals
Holmström, M. O., Ahmad, S. M., Klausen, U., Bendtsen, S. K., Martinenaite, E., Riley, C. H., Svane, Inge Marie, Kjær, L., Skov, V., Ellervik, Christina, Pallisgaard, N., Hasselbalch, H. C. & Andersen, Mads Hald, 2019, In: Blood Cancer Journal. 9, 2, 8.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immunoprofiles of colorectal cancer from Lynch syndrome
Walkowska, J., Kallemose, T., Jönsson, G., Jönsson, M., Andersen, Ove, Andersen, Mads Hald, Svane, Inge Marie, Langkilde, A., Nilbert, Mef Christina & Therkildsen, C., 2019, In: OncoImmunology. 8, 1, 9 p., e1515612.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Inflammation induced PD-L1-specific T cells
Munir, S., Lundsager, M. T., Jørgensen, M. A., Hansen, M., Petersen, T. H., Bonefeld, Charlotte Menne, Friese, C., Met, Özcan, Straten, P. T. & Andersen, Mads Hald, 2019, In: Cell Stress & Chaperones. 3, 10, p. 319-327Research output: Contribution to journal › Journal article › Research › peer-review
- Published
MERTK Acts as a costimulatory receptor on human cd8 t cells
Peeters, M. J. W., Dulkeviciute, D., Draghi, A., Ritter, C., Rahbech, A., Skadborg, S. K., Seremet, T., Simoes, A. M. C., Martinenaite, E., Halldorsdottir, H. R., Andersen, Mads Hald, Olofsson, G. H., Svane, Inge Marie, Rasmussen, Lene Juel, Met, Özcan, Becker, J. C., dqp123, dqp123, Desler, Claus & Straten, P. T., 2019, In: Cancer Immunology Research. 7, 9, p. 1472-1484 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Neo-antigen specific memory T-cell responses in healthy individuals
Holmström, M. O., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2019, In: OncoImmunology. 8, 7, 2 p., 1599640.Research output: Contribution to journal › Letter › Research › peer-review
- Published
Peripheral memory T cells specific for Arginase-1
Martinenaite, E., Ahmad, S. M., Svane, Inge Marie & Andersen, Mads Hald, 2019, In: Cellular and Molecular Immunology. 16, 8, p. 718-719 2 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy
Holmström, M. O., Novotny, G. W., Petersen, J., Aaboe-Jørgensen, M., Hasselbalch, Hans Carl, Andersen, Mads Hald, Nielsen, S. L., Fassi, Daniel El & Schöllkopf, C., 2019, In: Leukemia and Lymphoma. 60, 13, p. 3296-3299Research output: Contribution to journal › Letter › Research › peer-review
- Published
Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma
Blümel, E., Willerslev-Olsen, A., Gluud, Maria, Lindahl, L. M., Fredholm, S., Nastasi, C., Krejsgaard, T., Surewaard, B. G. J., Koralov, S. B., Hu, T., Persson, J. L., Bonefeld, Charlotte Menne, Geisler, Carsten, Iversen, L., Becker, J. C., Andersen, Mads Hald, Woetmann, Anders , Buus, Terkild Brink & Ødum, Niels, 2019, In: OncoImmunology. 8, 11, 7 p., e1641387.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Terapeutisk cancervaccination mod hæmatologisk cancer
Holmström, M. O., Grauslund, J. H., Dahlager-Jørgensen, N. G., Klausen, U., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2019, In: Ugeskrift for Laeger. 181, 20A, 5 p., V04190233.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The T-win® technology: immune-modulating vaccines
Andersen, Mads Hald, 2019, In: Seminars in Immunopathology. 41, 1, p. 87-95 9 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
The targeting of tumor-associated macrophages by vaccination
Andersen, Mads Hald, 2019, In: Cell Stress & Chaperones. 3, 5, p. 139-140Research output: Contribution to journal › Comment/debate › Research
- 2018
- Published
Immunoregulatory antigens-novel targets for cancer immunotherapy
Pedersen, A. W., Kopp, K. L., Andersen, Mads Hald & Zocca, M., Apr 2018, In: Chinese Clinical Oncology. 7, 2, p. 1-8 19.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytes
Kjaer, L., Holmström, M. O., Cordua, S., Andersen, Mads Hald, Svane, Inge Marie, Thomassen, M., Kruse, T. A., Pallisgaard, N., Skov, V. & Hasselbalch, Hans Carl, Apr 2018, In: Leukemia and Lymphoma. 59, 4, p. 973-977 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy
Holmstrom, M. O., Martinenaite, E., Ahmad, S. M., Met, Özcan, Friese, C., Kjaer, L., Riley, C. H., Straten, P. T., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 1 Feb 2018, In: Leukemia. 32, 2, p. 429-437Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Durable clinical responses and long-term follow-up of stage III-IV non-small-cell lung cancer (NSCLC) patients treated with IDO peptide vaccine in a phase i study-a brief research report
Kjeldsen, J. W., Iversen, T. Z., Engell-Noerregaard, L., Mellemgaard, A., Andersen, Mads Hald & Svane, Inge Marie, 2018, In: Frontiers in Immunology. 9, SEP, 6 p., 2145.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Frequent adaptive immune responses against arginase-1
Martinenaite, E., Mortensen, R. E. J., Hansen, M., Orebo Holmström, M., Munir Ahmad, S., Grønne Dahlager Jørgensen, N., Met, Özcan, dqp123, dqp123, Svane, Inge Marie & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 3, 9 p., e1404215.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin
Woetmann, Anders , Alhede, M., Dabelsteen, Sally, Bjarnsholt, Thomas, Rybtke, Morten Levin, Nastasi, C., Krejsgaard, T., Andersen, Mads Hald, Bonefeld, Charlotte Menne, Geisler, Carsten, Givskov, Michael & Ødum, Niels, 2018, In: OncoTarget. 9, 28, p. 19481-19489 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies
Klausen, U., Holmberg, S., Holmstrom, M. O., Jorgensen, N. G. D., Grauslund, J. H., Svane, Inge Marie & Andersen, Mads Hald, 2018, In: Frontiers in Immunology. 9, 8 p., 2264.Research output: Contribution to journal › Review › Research › peer-review
- Published
Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation
Jørgensen, M. A., Holmström, M. O., Martinenaite, E., Riley, C. H., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 9, 8 p., e1468957.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response
Holmström, M. O., Riley, C. H., Skov, V., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 6, e1433521.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The balance players of the adaptive immune system
Andersen, Mads Hald, 2018, In: Cancer Research. 78, 6, p. 1379-1382Research output: Contribution to journal › Review › Research › peer-review
- Published
The choriocarcinoma cell line JEG-3 upregulates regulatory T cell phenotypes and modulates pro-inflammatory cytokines through HLA-G
Melsted, W. N., Matzen, S. H., Andersen, Mads Hald & Hviid, Thomas Vauvert F., 2018, In: Cellular Immunology. 324, p. 14-23Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy
Ahmad, S. M., Martinenaite, E., Holmström, M., Jørgensen, M. A., Met, Özcan, Nastasi, C., Klausen, U., dqp123, dqp123, Pedersen, Lars Møller, Munksgaard, Lars, Ødum, Niels, Woetmann, Anders , Svane, Inge Marie & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 2, 10 p., e1390641.Research output: Contribution to journal › Journal article › Research › peer-review
- 2017
- Published
Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells
Nastasi, C., Fredholm, S., Willerslev-Olsen, A., Hansen, M., Bonefeld, Charlotte Menne, Geisler, Carsten, Andersen, Mads Hald, Ødum, Niels & Woetmann, Anders , Dec 2017, In: Scientific Reports. 7, 10 p., 14516.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs
Overgaard, N. H., Frøsig, T. M., Jakobsen, J. T., Buus, Søren, Andersen, Mads Hald & Jungersen, G., Oct 2017, In: Vaccine. 35, 42, p. 5629-5636 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling
Donia, M., Harbst, K., van Buuren, M., Kvistborg, P., Lindberg, M. F., Andersen, R., Idorn, M., Munir Ahmad, S., Ellebæk, E., Mueller, A., Fagone, P., Nicoletti, F., Libra, M., Lauss, M., Hadrup, S. R., Schmidt, H., Andersen, M. H., Thor Straten, P., Nilsson, J. A., Schumacher, T. N. & 3 others, , 1 Sep 2017, In: Cancer Research. 77, 17, p. 4562-4566 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cancer and autoimmunity
Andersen, Mads Hald, Apr 2017, In: Seminars in Immunopathology. 39, 3, p. 241-243 3 p.Research output: Contribution to journal › Editorial › Research › peer-review
- Published
Anti-regulatory T cells
Andersen, Mads Hald, 2017, In: Seminars in Immunopathology. 39, 3, p. 317–326 10 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma
Nitschke, N. J., Bjoern, J., Iversen, T. Z., Andersen, Mads Hald & Svane, Inge Marie, 2017, In: Stem Cell Investigation. 4, 13 p., 77.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Mikromiljøet som med- og modspiller i B-celle-non-Hodgkin-lymfomer
Klausen, U., Andersen, Mads Hald & Pedersen, Lars Møller, 2017, In: Ugeskrift for Læger. 179, 5 p., V03170220.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The JAK2V617F and CALR exon 9 mutations are shared immunogenic neoantigens in hematological malignancy
Holmstrom, M. O., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2017, In: OncoImmunology. 6, 11, 3 p., e1358334.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms
Holmström, M. O., Hjortso, M. D., Ahmad, S. M., Met, Özcan, Martinenaite, E., Riley, C., Straten, P., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2017, In: Leukemia. 31, p. 495-498Research output: Contribution to journal › Letter › Research › peer-review
- Published
The role of dendritic cells in cancer
Hansen, M. & Andersen, Mads Hald, 2017, In: Seminars in Immunopathology. 39, 3, p. 307-316Research output: Contribution to journal › Review › Research › peer-review
- 2016
- Published
GTn repeat polymorphism in heme oxygenase-1 (HO-1) correlates with clinical outcome after myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
Køllgaard, T., Kornblit, B., Petersen, J., Klausen, T. W., Mortensen, B. K., Brændstrup, P., Sengeløv, Henrik, Høgdall, Estrid Vilma Solyom, Muller, Klaus, Vindeløv, L., Andersen, Mads Hald & thor Straten, E. P., Dec 2016, In: PLoS ONE. 11, 12, 8 p., e0168210.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms
Holmström, M. O., Riley, C. H., Svane, Inge Marie, Hasselbalch, H. C. & Andersen, Mads Hald, Dec 2016, In: Leukemia. 30, 12, p. 2413-2416 14 p.Research output: Contribution to journal › Letter › Research › peer-review
- Published
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
Borch, T. H., Engell-Noerregaard, L., Iversen, T. Z., Ellebaek, E., Met, Özcan, Hansen, M., Andersen, Mads Hald, thor Straten, E. P. & Svane, Inge Marie, 1 Sep 2016, In: OncoImmunology. 5, 9, 12 p., e1207842.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21
Hansen, M., Met, Özcan, Larsen, N. B., Rosenkilde, Mette, Andersen, Mads Hald, Svane, Inge Marie & Hjortø, Gertrud Malene, Sep 2016, In: Cytotherapy. 18, 9, p. 1187-1196Research output: Contribution to journal › Journal article › Research › peer-review
- Published
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine
Munir Ahmad, S., Martinenaite, E., Hansen, M., Junker, N., Borch, T. H., Met, Özcan, Donia, M., Svane, Inge Marie & Andersen, Mads Hald, 2 Aug 2016, In: OncoImmunology. 5, 8, e1202391.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
Andersen, R., Donia, M., Ellebæk, E., Borch, T. H., Kongsted, P., Iversen, T. Z., Hølmich, Lisbet Rosenkrantz, Hendel, Helle Westergren, Met, Özcan, Andersen, Mads Hald, Thor Straten, E. P. & Svane, Inge Marie, Aug 2016, In: Clinical Cancer Research. 22, 15, p. 3734-3745 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab
Bjørn, J., Iversen, T. Z., Nitschke, N. J., Andersen, Mads Hald & Svane, Inge Marie, Aug 2016, In: Cytotherapy. 18, 8, p. 1043-1055 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
PD-L1-specific T cells
Ahmad, S. M., Borch, T. H., Hansen, M. & Andersen, Mads Hald, Jul 2016, In: Cancer Immunology, Immunotherapy. 65, 7, p. 797-804 8 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Novel understanding of self-reactive T cells
Andersen, Mads Hald, Mar 2016, In: OncoImmunology. 5, 3, 2 p., e1083672 .Research output: Contribution to journal › Editorial › Research › peer-review
- Published
Anti-regulatory T cells
Andersen, Mads Hald, 2016, Københavns Universitet.Research output: Book/Report › Doctoral thesis › Research
- Published
CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment
Martinenaite, E., Munir Ahmad, S., Hansen, M., Met, Özcan, Westergaard, M. W., Larsen, S. K., Klausen, T. W., Donia, M., Svane, Inge Marie & Andersen, Mads Hald, 2016, In: OncoImmunology. 5, 11, 10 p., e1238541.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial
Jørgensen, N. G., Ahmad, S. M., Abildgaard, N., Straten, P. T., Svane, Inge Marie, Andersen, Mads Hald & Knudsen, L. M., 2016, In: Stem Cell Investigation. 3, 5 p., 95.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma
Fredholm, S., Litvinov, I. V., Mongan, N. P., Schiele, S., Willerslev-Olsen, A., Petersen, D. L., Krejsgaard, T., Sibbesen, N., Nastasi, C., Bonefeld, Charlotte Menne, Persson, J. L., thor Straten, E. P., Andersen, Mads Hald, Koralov, S. B., Wasik, M. M., Geisler, Carsten, Sasseville, D., Woetmann, Anders & Ødum, Niels, 2016, In: Journal of Investigative Dermatology. 136, 4, p. 866-869 4 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
- 2015
- Published
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity
Donia, M., Andersen, R., Kjeldsen, J. W., Fagone, P., Munir, S., Nicoletti, F., Andersen, Mads Hald, Thor Straten, P. & Svane, Inge Marie, 15 Sep 2015, In: Cancer Research. 75, 18, p. 3747-59 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy
Andersen, Mads Hald, Sep 2015, In: National Cancer Institute. Journal (Online). 107, 9, p. 1-8 djv154.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies
Borch, T. H., Donia, M., Andersen, Mads Hald & Svane, Inge Marie, Sep 2015, In: Drug Discovery Today. 20, 9, p. 1127-34 8 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Oncogenic cancer/testis antigens: prime candidates for immunotherapy
Gjerstorff, M. F., Andersen, Mads Hald & Ditzel, H. J., 30 Jun 2015, In: OncoTarget. 6, 18, p. 15772-87 16 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Profound Endothelial Damage Predicts Impending Organ Failure and Death in Sepsis
Johansen, M. E., Johansson, P. I., Ostrowski, Sisse Rye, Bestle, Morten Heiberg, Hein, L., Jensen, A. L. G., Søe-Jensen, P., Andersen, Mads Hald, Steensen, M., Mohr, T., Thormar, K., Lundgren, B., Cozzi-Lepri, A., Lundgren, Jens & Jensen, J., Feb 2015, In: Seminars in Thrombosis and Hemostasis. 41, 1, p. 16-25 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The Targeting of Indoleamine 2,3 Dioxygenase -Mediated Immune Escape in Cancer
Iversen, T. Z., Andersen, Mads Hald & Svane, Inge Marie, Jan 2015, In: Basic & Clinical Pharmacology & Toxicology. 116, 1, p. 19-24 6 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer
Hjortsø, M. D., Larsen, S. K., Kongsted, P., Met, Özcan, Frøsig, T. M., Andersen, G. H., Ahmad, S. M., Svane, Inge Marie, Becker, J. C., Straten, P. T. & Andersen, Mads Hald, Jan 2015, In: OncoImmunology. 4, 1, e968480.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Establishing the pig as a large animal model for vaccine development against human cancer
Overgaard, N. H., Frøsig, T. M., Welner, S., Rasmussen, M., Ilsøe, M., Sørensen, M. R., Andersen, Mads Hald, Buus, Søren & Jungersen, G., 2015, In: Frontiers in Genetics. 6, 12 p., 286.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Indoleamine 2,3-dioxygenase vaccination
Andersen, Mads Hald & Svane, Inge Marie, 2015, In: OncoImmunology. 4, 1, p. 1-3 3 p., e983770.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes
Køllgaard, T., Ugurel-Becker, S., Idorn, M., Andersen, Mads Hald, Becker, J. C. & thor Straten, E. P., 2015, In: P L o S One. 10, 7, 14 p., e0131934.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The effect of short-chain fatty acids on human monocyte-derived dendritic cells
Nastasi, C., Candela, M., Bonefeld, Charlotte Menne, Geisler, Carsten, Hansen, M., Krejsgaard, T., Biagi, E., Andersen, Mads Hald, Brigidi, P., Ødum, Niels, Litman, T. & Woetmann, Anders , 2015, In: Scientific Reports. 5, 10 p., 16148.Research output: Contribution to journal › Journal article › Research › peer-review
- 2014
- Published
Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
Iversen, T. Z., Engell-Noerregaard, L., Ellebaek, E., Andersen, R. S., Larsen, S. K., Bjoern, J., Zeyher, C., Gouttefangeas, C., Thomsen, B. M., Holm, B., Thor Straten, P., Mellemgaard, A., Andersen, Mads Hald & Svane, Inge Marie, 1 Jan 2014, In: Clinical Cancer Research. 20, 1, p. 221-232 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Spontaneous presence of FOXO3-specific T cells in cancer patients
Larsen, S. K., Ahmad, S. M., Idorn, M., Met, Özcan, Martinenaite, E., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 1 Jan 2014, In: OncoImmunology. 3, 8, e953411.Research output: Contribution to journal › Journal article › Research › peer-review
- 2013
- Published
Functional characterization of Foxp3-specific spontaneous immune responses
Larsen, S. K., Munir, S., Woetmann, Anders , Frøsig, T. M., Ødum, Niels, Svane, Inge Marie, Becker, J. C. & Andersen, Mads Hald, Dec 2013, In: Leukemia. 27, 12, p. 2332-40 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cutaneous T cell lymphoma cells are targets for immune checkpoint ligand PD-L1-specific, cytotoxic T cells
Munir, S., Andersen, G. H., Woetmann, Anders , Ødum, Niels, Becker, J. C. & Andersen, Mads Hald, Nov 2013, In: Leukemia. 27, 11, p. 2251-3 3 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients
Munir, S., Andersen, G. H., Met, Özcan, Donia, M., Frøsig, T. M., Larsen, S. K., Klausen, T. W., Svane, Inge Marie & Andersen, Mads Hald, 15 Mar 2013, In: Cancer Research. 73, 6, p. 1764-76 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells
Munir, S., Andersen, G. H., Svane, Inge Marie & Andersen, Mads Hald, 2013, In: OncoImmunology. 2, 4, 9 p., e23991.Research output: Contribution to journal › Journal article › Research › peer-review
- 2012
- Published
Characterization and comparison of "Standard" and "Young" tumor infiltrating lymphocytes for adoptive cell therapy at a Danish Translational Research Institution
Donia, M., Junker, N., Ellebaek, E., Andersen, Mads Hald, Straten, P. T. & Svane, Inge Marie, 2012, In: Scandinavian Journal of Immunology. 75, 2, p. 157-167 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures
Junker, N., Kvistborg, P., Køllgaard, T., Straten, P. T., Andersen, Mads Hald & Svane, Inge Marie, 2012, In: Cellular Immunology. 273, 1, p. 1-9 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2011
- Submitted
PD-L1 based Immunotherapy
Andersen, Mads Hald, 17 Oct 2011, (Submitted) 17 Oct 2011Research output: Patent
- Published
Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial
Jensen, J. U., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T. T., Andersen, M. H., Thornberg, K. J., Løken, J., Steensen, M., Fox, Z., Tousi, H., Søe-Jensen, P., Lauritsen, A. Ø., Strange, D., Petersen, P. L., Reiter, N., Hestad, S., Thormar, K., Fjeldborg, P., Larsen, K. M. & 6 others, , 1 Sep 2011, In: Critical Care Medicine. 39, 9, p. 2048-58 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination
Straten, P. T. & Andersen, Mads Hald, 12 May 2011, In: Vaccine. 29, 21, p. 3728Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer
Junker, N., Andersen, Mads Hald, Wenandy, L., Dombernowsky, S. L., Kiss, K., Sørensen, C. H., Therkildsen, M. H., Buchwald, C. V., Andersen, E., Straten, P. T., Svane, Inge Marie & Andersen, Mads Hald, 24 Mar 2011, In: Cytotherapy. 13, 7, p. 822-34Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2
Sørensen, R. B., Køllgaard, T., Andersen, R. S., van den Berg, J. H., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 15 Mar 2011, In: Cancer Research. 71, 6, p. 2038-44 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators
Sørensen, R. B., Hadrup, S. R., Svane, Inge Marie, Hjortsø, M. C., Thor Straten, P., Andersen, Mads Hald, Hjortsø, M. C. & Andersen, Mads Hald, 17 Feb 2011, In: Blood. 117, 7, p. 2200-10 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A potential role of indoleamine 2,3-dioxygenase-specific T cells in leishmania vaccination
thor Straten, P. & Andersen, Mads Hald, 2011, In: Journal of Infectious Diseases. 204, 3, p. 488-9 2 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer
Junker, N., Andersen, Mads Hald, Wenandy, L., Dombernowsky, S. L., Kiss, K., Sørensen, C. H., Therkildsen, M. H., von Buchwald, Christian, Andersen, E., Straten, P. T. & Svane, Inge Marie, 2011, In: Cytotherapy. 13, 7, p. 822-34 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2
Bjoern, J., Brimnes, M. K., Andersen, Mads Hald, Straten, P. T. & Svane, Inge Marie, 2011, In: Scandinavian Journal of Immunology. 73, 3, p. 222-33 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application
Junker, N., Thor Straten, P., Andersen, Mads Hald & Svane, Inge Marie, 2011, In: Journal of Skin Cancer. 2011, 574695, 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
HLA-A2-restricted survivin-derived T-cell responses
Straten, P. T. & Andersen, Mads Hald, 2011, In: Vaccine. 29, 52, p. 9582Research output: Contribution to journal › Letter › Research › peer-review
- Published
Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors
Andersen, R. S., Sørensen, R. B., Ritter, C., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2011, In: Cancer Immunology, Immunotherapy. 60, 2, p. 227-34 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Submitted
- 2010
- Published
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
Trepiakas, R., Berntsen, A., Hadrup, S. R., Bjørn, J., Geertsen, P. F., Straten, P. T., Andersen, Mads Hald, Pedersen, Anders Elm, Soleimani, A., Lorentzen, T., Johansen, Julia Sidenius & Svane, Inge Marie, 1 Oct 2010, In: Cytotherapy. 12, 6, p. 721-34 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens
Straten, P. T., Andersen, Mads Hald & Andersen, Mads Hald, 1 Aug 2010, In: OncoTarget. 1, 4, p. 239-45 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Therapeutic cancer vaccines in combination with conventional therapy
Andersen, Mads Hald, Junker, N., Ellebaek, E., Svane, Inge Marie, Thor Straten, P. & Andersen, Mads Hald, 1 Jan 2010, In: Journal of Biomedicine and Biotechnology. 2010, p. 237623Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Combined Treatment with Dendritic Cell Vaccine and Low-Dose Cyclophosphamide in Patients with Malignant Melanoma
Engell-Noerregaard, L., Ellebaek, E., Buch-Hansen, T. Z., Nikolajsen, K., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876-877 2 p.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Dendritic Cells Transfected with mRNA for p53, Survivin and hTERT as Treatment for Patients With Malignant Melanoma or Breast Cancer-A Phase I Study
Engell-Noerregaard, L., Hansen, T. H., Met, Ö., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876 1 p.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Spontaneous Cytotoxic T cell Reactivity Against IDO Exists in Cancer Patients and in Healthy Donors
Sørensen, R. B., Straten, P. T., Andersen, Mads Hald & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 910-911 2 p.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial
Buch-Hansen, T. Z., Sørensen, R. B., Mellemgaard, A., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 919-920 2 p.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Therapeutic cancer vaccines
Larsen, S. K., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 2010, In: Current Cancer Therapy Reviews. 6, 2, p. 163-174Research output: Contribution to journal › Journal article › Research › peer-review
- 2009
- Published
Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56
Baek Sørensen, R., Faurschou, M., Troelsen, L., Schrama, D., Jacobsen, S., Becker, J. C., Thor Straten, P., Andersen, Mads Hald, Baek Sørensen, R., Faurschou, M., Troelsen, L., Schrama, D., Jacobsen, Søren, Becker, J. C., Thor Straten, P. & Andersen, M. H., 1 Aug 2009, In: Journal of Investigative Dermatology. 129, 8, p. 1992-9 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53
Sørensen, R. B., Andersen, R. S., Svane, Inge Marie, Engell-Noerregaard, L., Hadrup, S. R., Balslev, E., Andersen, Mads Hald & thor Straten, P., 2009, In: Clinical Cancer Research. 15, 5, p. 1543-9 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression"
Sørensen, R. B., thor Straten, P. & Andersen, Mads Hald, 2009, In: Journal of Immunology. 183, 10, p. 6040 1 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes
Hofmann, U. B., Voigt, H., Andersen, Mads Hald, Straten, P. T., Becker, J. C. & Eggert, A. O., 2009, In: European Journal of Immunology. 39, 5, p. 1419-24 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients
Andersen, Mads Hald, Sørensen, R. B., Brimnes, M. K., Svane, Inge Marie, Becker, J. C. & thor Straten, P., 2009, In: Journal of Clinical Investigation. 119, 8, p. 2245-56 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients
Hofmeister-Mueller, V., Vetter-Kauczok, C. S., Ullrich, R., Meder, K., Lukanidin, E., Broecker, E., Straten, P. T., Andersen, Mads Hald, Schrama, D. & Becker, J. C., 2009, In: Cancer Immunology, Immunotherapy. 58, 8, p. 1265-73 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709)
Køllgaard, T., Duval, L., Schmidt, H., Kaltoft, K., Seremet, T., Andersen, Mads Hald, Maase, H. V. D., Straten, P. T. & Hadrup, S. R., 2009, In: Cytotherapy. 11, 5, p. 631-41 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters
Engell-Noerregaard, L., Hansen, T. H., Andersen, Mads Hald, Thor Straten, P. & Svane, Inge Marie, 2009, In: Cancer Immunology, Immunotherapy. 58, 1, p. 1-14 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase
Sørensen, R. B., Berge-Hansen, L., Junker, N., Hansen, C. A., Hadrup, S. R., Schumacher, T. N. M., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2009, In: PLoS ONE. 4, 9, p. e6910Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines
Sørensen, R. B., Junker, N., Kirkin, A., Voigt, H., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2009, In: Cancer Immunology, Immunotherapy. 58, 5, p. 665-75 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 13571778
Most downloads
-
216
downloads
Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
170
downloads
Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
169
downloads
Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin
Research output: Contribution to journal › Journal article › Research › peer-review
Published